CLU and prostate cancer: Many factors indicate that clusterin is involved in the mechanism of regulation of contrary processes such as cell survival and apoptosis [91], which has been observed both in colon cancer [90, 92] and other types of cancer, e.g., bladder cancer [93], kidney cancer [52], and prostate cancer [94].